Abstract
The flow of information from DNA to proteins is governed by two macro--molecular ribozymes: the spliceosome and the ribosome. The spliceosome is a multisubunit machine found in all eukaryotes, which searches transcripts for a class of intervening sequences named introns in order to splice them out of the message. Alternative splicing allows several transcripts to be obtained from one single gene, thus greatly diversifying the coding potential of eukaryotic genomes. 5 spliceosomal small nuclear RNAs (snRNAs) comprise the building blocks of the spliceosome, with U6 snRNA playing the central catalytic role. Spliceosomes are highly dynamic complexes, assembled anew on every intron from a snRNA pool and protein cofactors. Upon completion of splicing the spliceosome is disassembled and the components can be recycled in new spliceosomes.
The path of U6 snRNA towards an assembling spliceosome starts with transcription by the RNA polymerase III machinery. U6 snRNA undergoes a number of maturation steps, one of them being the addition of nontemplated uridines to its 3' terminus by the U6--specific TUTase enzyme. TUTase generates poly(U) tracts terminating with 2',3'--cis--diol groups, however the predominant form of U6 snRNA in various model organisms bears a 3' terminal tract with 5 uridines blocked by a 2',3'--cyclic phosphate group. In vivo the 3' terminus of mature U6 snRNA is bound by the conserved Lsm2--8 complex. While the existence of activities that trim the poly(U) tract of U6 snRNA and that convert the 2',3'--cis--diol into 2',3'--cyclic phosphate have been known to exist for long time, the identity of the polypeptides that bear this activity has remain unknown. We have now shown that Mpn1, a conserved member of the 2H superfamily of phosphodiesterases, exerts both activities in fission yeasts and in humans. The MPN1 gene is mutated in all patients diagnosed with a rare genodermatosis known as Clericuzio--type poikiloderma with neutropenia. Both in yeasts and humans Mpn1--deficient cells accumulate U6 snRNA species carrying aberrantly extended uridine tracts terminated with adenine residues. Furthermore, U6 snRNA stability was compromised and U6--Lsm complex formation was severely diminished in mpn1 mutants. We also demonstrated that Rrp6 exonuclease promotes U6 degradation in Mpn1--deficient cells and that, at least in human cells, U6 snRNA is not the only substrate for Mpn1. Our data represent the first step towards the understanding of the molecular role of Mpn1 in living cells, offering a framework for the development of therapeutic approaches to cure poikiloderma with neutropenia. 
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